Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene

被引:56
作者
EL Naaman, C
Grum-Schwensen, B
Mansouri, A
Grigorian, M
Santoni-Rugiu, E
Hansen, T
Kriajevska, M
Schafer, BW
Heizmann, CW
Lukanidin, E
Ambartsumian, N
机构
[1] Danish Canc Soc, Dept Mol Canc Biol, DK-2100 Copenhagen, Denmark
[2] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany
[3] Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark
[4] Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland
关键词
animal models; Mts1(S100A4); p53; tumor development; tumor suppressor activity;
D O I
10.1038/sj.onc.1207420
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Metastasis-promoting Mts1(S100A4) protein belongs to the S100 family of Ca2+-binding proteins. A mouse strain with a germ-line inactivation of the S100A4 gene was generated. The mice were viable and did not display developmental abnormalities in the postnatal period. However, an abnormal sex ratio was observed in the litters with the S100A4-/- genotype, raising the possibility of a certain level of embryonic lethality in this strain. In all, 10% of 10-14-month-old S100A4-null animals developed tumors. This is a characteristic feature of mouse strains with inactivated tumor suppressor genes. Spontaneous tumors of S100A4-/- mice were p53 positive. Recently, we have shown that S100A4 interacts with p53 tumor suppressor protein and induces apoptosis. We proposed that impairment of this interaction could affect the apoptosis-promoting function of p53 that is involved in its tumor suppressor activity. The frequency of apoptosis in the spleen of S100A4-/- animals after whole-body gamma-irradiation was reduced compared to the wild-type animals. The same was true for the transcriptional activation of the p53 target genes - waf/p21/cip1 and bax. Taken together, these observations indicate that spontaneous tumors in S100A4-/- mice are a result of functional destabilization of p53 tumor suppressor gene.
引用
收藏
页码:3670 / 3680
页数:11
相关论文
共 79 条
[1]
Psoriasin (S100A7) expression and invasive breast cancer [J].
Al-Haddad, S ;
Zhang, Z ;
Leygue, E ;
Snell, L ;
Huang, AH ;
Niu, YL ;
Hiller-Hitchcock, T ;
Hole, K ;
Murphy, LC ;
Watson, PH .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :2057-2066
[2]
The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor [J].
Ambartsumian, N ;
Klingelhöfer, J ;
Grigorian, M ;
Christensen, C ;
Kriajevska, M ;
Tulchinsky, E ;
Georgiev, G ;
Berezin, V ;
Bock, E ;
Rygaard, J ;
Cao, RH ;
Cao, YH ;
Lukanidin, E .
ONCOGENE, 2001, 20 (34) :4685-4695
[3]
Ambartsumian N, 1999, INVAS METAST, V18, P96
[4]
Ambartsumian NS, 1996, ONCOGENE, V13, P1621
[5]
HIGH-FREQUENCY DEVELOPMENTAL ABNORMALITIES IN P53-DEFICIENT MICE [J].
ARMSTRONG, JF ;
KAUFMAN, MH ;
HARRISON, DJ ;
CLARKE, AR .
CURRENT BIOLOGY, 1995, 5 (08) :931-936
[6]
Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter [J].
Bian, JH ;
Sun, Y .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) :6330-6338
[7]
TP53 and breast cancer [J].
Borresen-Dale, AL .
HUMAN MUTATION, 2003, 21 (03) :292-300
[8]
Further characterisation of the p53 responsive element - Identification of new candidate genes for trans-activation by p53 [J].
Bourdon, JC ;
DeguinChambon, V ;
Lelong, JC ;
Dessen, P ;
May, P ;
Debuire, B ;
May, E .
ONCOGENE, 1997, 14 (01) :85-94
[9]
Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice [J].
Bouvard, V ;
Zaitchouk, T ;
Vacher, M ;
Duthu, A ;
Canivet, M ;
Choisy-Rossi, C ;
Nieruchalski, M ;
May, E .
ONCOGENE, 2000, 19 (05) :649-660
[10]
Studies of oncogene activation and tumor suppressor gene inactivation in normal and neoplastic rodent tissue [J].
Buzard, GS .
MUTATION RESEARCH-REVIEWS IN GENETIC TOXICOLOGY, 1996, 365 (1-3) :43-58